somatoKine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2008
012320002008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
BACKGROUND Mecasermin rinfabate (iPLEX), comprising rhIGF-I complexed to rhIGFBP-3, was developed in an attempt to prolong the… (More)
Is this relevant?
2006
2006
OBJECTIVE Young adults with type 1 diabetes mellitus (T1DM) have increased glomerular filtration rate (GFR), which may mediate… (More)
Is this relevant?
2006
2006
BACKGROUND The lack of catch up growth (CUG) in small for gestational age (SGA) children may be related to a reduced sensitivity… (More)
Is this relevant?
Review
2005
Review
2005
Growth hormone (GH) has been used to treat GH deficiency since the late 1950s, and recombinant GH has been available since 1985… (More)
Is this relevant?
Review
2005
Review
2005
  • Drugs in R&D
  • 2005
Insmed is developing mecasermin rinfabate, a recombinant complex of insulin-like growth factor-I (rhIGF-I) and binding protein-3… (More)
Is this relevant?
2005
2005
An important molecule for growth recently received approval in the US. This approval heralds the first medical application of… (More)
Is this relevant?
Review
2003
Review
2003
SomatoKine, a recombinant fusion of insulin-like growth factor-1 and its binding protein, BP-3, is being developed by Insmed… (More)
Is this relevant?
2003
2003
  • BioDrugs : clinical immunotherapeutics…
  • 2003
Somatomedin-1 binding protein-3 [insulin-like growth factor-1 binding protein-3, SomatoKine] is a recombinant complex of insulin… (More)
Is this relevant?
2000
2000
BACKGROUND The aim of this study was to evaluate the effect of insulin like growth factor-I (rhIGF-I) in complex with binding… (More)
Is this relevant?